Literature DB >> 20448015

Acute hepatic encephalopathy: diffusion-weighted and fluid-attenuated inversion recovery findings, and correlation with plasma ammonia level and clinical outcome.

A M McKinney1, B D Lohman, B Sarikaya, E Uhlmann, J Spanbauer, T Singewald, J R Brace.   

Abstract

BACKGROUND AND
PURPOSE: In acute hepatic encephalopathy, MR imaging abnormalities have been described in the PVWM, thalami, and corticospinal tracts. We sought to determine characteristic regions of involvement on FLAIR and DWI, to evaluate their reversibility, and to correlate MR imaging extent with clinical severity.
MATERIALS AND METHODS: Twenty patients who presented clinically with acute hepatic encephalopathy and MR imaging <21 days after symptom onset were reviewed retrospectively. Two neuroradiologists recorded involved regions on FLAIR and DWI in each, measured ADC values in affected regions and NAWM, and scored the MR imaging severity/extent. The initial severity (West Haven grade), follow-up clinical severity (degree of improvement), and maximal PAL within ±8 days of MR imaging were recorded and correlated with the MR imaging severity.
RESULTS: On FLAIR and DWI respectively, there were abnormalities in the thalami (85%, 70%), PLIC (75%, 80%), PVWM (80%, 85%), and DBS (70%, 35%) and diffuse cortical involvement (30%, 25%). There were relatively strong significant (P < .005) correlations of FLAIR (r = 0.680, P = .001) and DWI severity (r = 0.690, P = .001) with PAL, and of PAL with the clinical outcome (r = 0.691, P = .001). Both FLAIR (r = 0.592, P = .006) and DWI (r = 0.487, P = .029) severity correlated moderately with the clinical outcome but were not significant at the P < .005 level after Bonferroni correction.
CONCLUSIONS: Patients with acute hepatic encephalopathy may exhibit characteristic regions of involvement on FLAIR with DWI findings that can be reversible. The MR imaging extent on FLAIR and DWI strongly correlates with the maximal PAL, and PAL correlates well with the clinical outcome. Diffuse cortical involvement has a higher potential for neurologic sequelae but can be reversible.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20448015      PMCID: PMC7966093          DOI: 10.3174/ajnr.A2112

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  30 in total

1.  Evaluation of plasma ammonia levels in patients with acute liver failure and chronic liver disease and its correlation with the severity of hepatic encephalopathy and clinical features of raised intracranial tension.

Authors:  Arun Kundra; Anil Jain; Alok Banga; Girish Bajaj; Premasish Kar
Journal:  Clin Biochem       Date:  2005-08       Impact factor: 3.281

2.  Measurement of cytotoxic and interstitial components of cerebral edema in acute hepatic failure by diffusion tensor imaging.

Authors:  Vijan Rai; Kavindra Nath; Vivek A Saraswat; Ankur Purwar; Ram K S Rathore; Rakesh K Gupta
Journal:  J Magn Reson Imaging       Date:  2008-08       Impact factor: 4.813

Review 3.  An image of the brain in patients with liver disease.

Authors:  A H Lockwood; K Weissenborn; R F Butterworth
Journal:  Curr Opin Neurol       Date:  1997-12       Impact factor: 5.710

Review 4.  Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy.

Authors:  V-P Bob Grover; M-Alex Dresner; Daniel-M Forton; Serena Counsell; David-J Larkman; Nayna Patel; Howard-C Thomas; Simon-D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742

5.  Cerebral cortical and white matter lesions in chronic hepatic encephalopathy: MR-pathologic correlations.

Authors:  Eiji Matsusue; Toshibumi Kinoshita; Eisaku Ohama; Toshihide Ogawa
Journal:  AJNR Am J Neuroradiol       Date:  2005-02       Impact factor: 3.825

Review 6.  Pathogenetic mechanisms of hepatic encephalopathy.

Authors:  D Häussinger; F Schliess
Journal:  Gut       Date:  2008-08       Impact factor: 23.059

7.  Magnetic resonance analysis of the effects of acute ammonia intoxication on rat brain. Role of NMDA receptors.

Authors:  Omar Cauli; Pilar López-Larrubia; Tiago B Rodrigues; Sebastián Cerdán; Vicente Felipo
Journal:  J Neurochem       Date:  2007-08-28       Impact factor: 5.372

8.  Acute toxic leukoencephalopathy: potential for reversibility clinically and on MRI with diffusion-weighted and FLAIR imaging.

Authors:  Alexander M McKinney; Stephen A Kieffer; Rogerich T Paylor; Karen S SantaCruz; Ayse Kendi; Leandro Lucato
Journal:  AJR Am J Roentgenol       Date:  2009-07       Impact factor: 3.959

9.  Diffusion abnormalities of the globi pallidi in manganese neurotoxicity.

Authors:  Alexander M McKinney; Ross W Filice; Mehmet Teksam; Sean Casey; Charles Truwit; H Brent Clark; Carolyn Woon; Hai Ying Liu
Journal:  Neuroradiology       Date:  2004-03-25       Impact factor: 2.804

Review 10.  Hepatic encephalopathy.

Authors:  Roger F Butterworth
Journal:  Alcohol Res Health       Date:  2003
View more
  23 in total

Review 1.  Multimodality MR imaging findings of low-grade brain edema in hepatic encephalopathy.

Authors:  L J Zhang; J Zhong; G M Lu
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-01       Impact factor: 3.825

2.  Diffusion-weighted imaging in acute hyperammonemic encephalopathy.

Authors:  Michael Rosario; Kevin McMahon; Pasquale F Finelli
Journal:  Neurohospitalist       Date:  2013-07

3.  Acute hepatic (or hyperammonemic) encephalopathy: diffuse cortical injury and the significance of ammonia.

Authors:  A M McKinney; B Sarikaya; J Spanbauer; B D Lohman; E Uhlmann
Journal:  AJNR Am J Neuroradiol       Date:  2011-06-30       Impact factor: 3.825

Review 4.  Multimodal MR imaging in hepatic encephalopathy: state of the art.

Authors:  Xiao Dong Zhang; Long Jiang Zhang
Journal:  Metab Brain Dis       Date:  2018-01-26       Impact factor: 3.584

5.  Clinical impact of preoperative brain MR angiography and MR imaging in candidates for liver transplantation: a propensity score-matching study in a single institution.

Authors:  Mi Sun Chung; Ho Sung Kim; Young-Suk Lim; Sang-Beom Jeon; Seon-Ok Kim; Hwa Jung Kim; Shin Hwang; Seung Chai Jung; Choong Gon Choi; Sang Joon Kim
Journal:  Eur Radiol       Date:  2017-01-20       Impact factor: 5.315

Review 6.  Potentially Reversible and Recognizable Acute Encephalopathic Syndromes: Disease Categorization and MRI Appearances.

Authors:  Y Koksel; A M McKinney
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-02       Impact factor: 3.825

7.  Acute hepatic encephalopathy presenting as cortical laminar necrosis: case report.

Authors:  Jong Mun Choi; Yoon Hee Kim; Sook Young Roh
Journal:  Korean J Radiol       Date:  2013-02-22       Impact factor: 3.500

Review 8.  Encephalopathy and liver transplantation.

Authors:  Laia Chavarria; Juan Cordoba
Journal:  Metab Brain Dis       Date:  2012-11-16       Impact factor: 3.584

Review 9.  Multimodality magnetic resonance imaging in hepatic encephalopathy: an update.

Authors:  Xiao-Dong Zhang; Long-Jiang Zhang; Sheng-Yong Wu; Guang-Ming Lu
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

10.  Utility and Significance of Gadolinium-Based Contrast Enhancement in Posterior Reversible Encephalopathy Syndrome.

Authors:  S J Karia; J B Rykken; Z J McKinney; L Zhang; A M McKinney
Journal:  AJNR Am J Neuroradiol       Date:  2015-11-12       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.